Home
Conditions
Carcinogenesis

Clinical trial condition

Carcinogenesis

Explore clinical trials studying Carcinogenesis. Study availability and eligibility vary by location and protocol.

271 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Carcinogenesis trial results

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions: Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations: CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Centre Hospitalier Universitaire Henri Mondor Créteil, France

Hopital Edouard Herriot - Lyon Lyon, France

Hopital Saint-Louis Paris, France

View all 13 locations

View Trial Details

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
Locations: A.Z. St. Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 24 locations

View Trial Details

Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions: Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Boston Medical Center Boston, Massachusetts, United States

Algemeen Ziekenhuis Middelheim Antwerp, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 28 locations

View Trial Details

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations: Jennie Stuart Medical Center Hopkinsville, Kentucky, United States

Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States

Erlanger Health System Chattanooga, Tennessee, United States

Tennessee Plateau Oncology Crossville, Tennessee, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +26 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00002832

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

NCT00732316

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

NCT00816283

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations: Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States

Johns Hopkins Oncology Center Baltimore, Maryland, United States

New England Medical Center Hospital Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View all 13 locations

View Trial Details

Completed

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

NCT00004230

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Carcinogenesis

Carcinogenesis trial results

Related conditions